Atlas Trials

Atezolizumab After Chemo-radiotherapy for MIBC Patients Not Eligible for Radical Cystectomy

Clinical trial NCT03697850 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03697850
Sponsor
UNICANCER
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2018-12-14
Primary completion
2025-06-15
Enrollment
79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.